These findings pinpoint to a potential tumor-suppressive role, similar to that established in mice, of GPRC5A in the sequential development of human NSCLC, in particular those associated with inflammatory chronic obstructive disease which is a major risk factor for lung cancer and shares various pathogenic features with lung tumor (Wistuba and Gazdar 2006). The gene discussed is GPRC5A; the disease is lung cancer.